First Study Using Biomimetic AI Digital Twins and Multiomics in Genetics Research

HAUPPAUGE, N.Y. — ROCKVILLE, MD – Revolutionary genomic research by Genzeva, LumaGene, RYLTI, Brigham & Women’s Hospital of Harvard University, and QIAGEN Digital Insights applied an innovative use of multiomics and biomimetic digital twins to unveil new DNA variants associated with the development of endometrial related disorders. This study marks a significant leap forward in understanding the molecular mechanisms of endometrial-related disorders.

See the full article on these sites:

https://www.ciodive.com/press-release/20240411-first-study-using-biomimetic-ai-digital-twins-and-multiomics-in-genetics-re/

https://www.biopharmadive.com/press-release/20240411-first-study-using-biomimetic-ai-digital-twins-and-multiomics-in-genetics-re/

Note: This is recent news about our technology partner, RYLTI.